Advanced Flower CapitalAFCG
AFCG logo
Fair Value
US$8
Share price26 Jun
US$3.1360.9% undervalued intrinsic discount
Loading
1Y-33.40%
7D0%

BDC Conversion And Federal Shifts Will Expand Lending Across Sectors

Analyst Consensus Target compiles analysts opinions to create narratives on stocks using the Analysts Consensus Price Target, forecasted revenue and earnings figures, as well as the transcripts of earnings calls.

Published
26 Sep 24
Updated
26 Jun 26
Views
164
Not Invested

Last Update 26 Jun 26

Fair value Increased 52%

AFCG: Share Repurchase Program Will Drive Long-Term Upside Potential

Analysts have raised the price target on Advanced Flower Capital from $5.25 to $8.00, citing updated assumptions about its discount rate, profit margin outlook, and future P/E as key drivers of the revised valuation.

What’s in the News for Advanced Flower Capital

  • Advanced Flower Capital Inc. announced a share repurchase program authorizing the company to buy back up to US$5 million of its common stock, with the plan valid until May 4, 2027. (Source: Key Developments)
  • The Board of Directors of Advanced Flower Capital Inc. authorized a buyback plan on May 4, 2026, providing a formal framework for the share repurchase activity. (Source: Key Developments)

Valuation Changes

  • Fair Value: revised from $5.25 to $8.00, representing a substantial upward adjustment in the valuation estimate for Advanced Flower Capital.
  • Discount Rate: reduced from 12.33% to 9.24%, indicating a lower required return in the updated model.
  • Revenue Growth: adjusted from 208.90% to 171.68%, reflecting a lower growth rate assumption while still implying a high growth multiple.
  • Profit Margin: increased from 65.20% to 71.68%, indicating a higher assumed level of profitability on future revenue.
  • Future P/E: lowered from 8.52x to 6.94x, indicating a more conservative earnings multiple applied to Advanced Flower Capital in the new valuation.
3 viewsusers have viewed this narrative update

Key Takeaways

  • Broadening the investment mandate and transitioning to a BDC will expand AFC's addressable market, borrower diversity, and revenue growth opportunities.
  • Limited competition in cannabis finance and potential regulatory changes position AFC for stronger margins, asset recoveries, and resilient earnings.
  • Legacy loan issues, cannabis sector risks, strategic shift, financing constraints, and regulatory uncertainty threaten earnings stability, growth opportunities, and long-term profitability.

Catalysts

About Advanced Flower Capital
    Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry.
What are the underlying business or industry changes driving this perspective?
  • Expanding the investment mandate through proposed conversion to a BDC will allow AFC to lend to a far broader universe of cannabis operators-including those without real estate assets-as well as ancillary and non-cannabis middle market companies, which could significantly increase addressable market, pipeline size, and revenue growth.
  • Expected federal rescheduling of cannabis, if it materializes, would improve cash flows and valuations for borrowers by removing punitive tax regimes (e.g., 280E), likely reducing loan loss reserves and improving net margins and reported earnings via better recoveries on underperforming loans.
  • Increasing societal normalization and demand for cannabis continues to drive overall industry expansion, leading to more and larger borrowers and heightened need for non-bank finance, supporting sustained top line growth for AFC as it captures emerging opportunities.
  • Continued banking hesitancy toward the cannabis sector provides AFC with strong pricing power and limited direct competition in specialty finance, helping to maintain elevated loan yields and healthy net interest margins compared to traditional REIT peers.
  • Diversification of the loan book across more borrowers, states, and industries-once the BDC transition is complete-reduces concentration risk and the impact of individual credit events, leading to improved revenue stability and resilience in distributable earnings.
Advanced Flower Capital Earnings and Revenue Growth

Advanced Flower Capital Future Earnings and Revenue Growth

Assumptions

How have these above catalysts been quantified?

  • Analysts are assuming Advanced Flower Capital's revenue will grow by 171.7% annually over the next 3 years.
  • Analysts assume that profit margins will increase from -499.4% today to 71.7% in 3 years time.
  • Analysts expect earnings to reach $39.1 million (and earnings per share of $0.96) by about June 2029, up from -$13.6 million today.
  • In order for the above numbers to justify the price target of the analysts, the company would need to trade at a PE ratio of 7.1x on those 2029 earnings, up from -5.5x today. This future PE is lower than the current PE for the US Capital Markets industry at 39.7x.
  • Analysts expect the number of shares outstanding to grow by 4.14% per year for the next 3 years.
  • To value all of this in today's terms, we will use a discount rate of 9.24%, as per the Simply Wall St company report.

Risks

What could happen that would invalidate this narrative?
  • The company is still dealing with a significant number of underperforming and troubled legacy loans, including assets in liquidation and loans on nonaccrual status, which continues to pressure earnings, increase loan loss reserves, and contribute to a large GAAP net loss, putting ongoing strain on distributable earnings and net margins.
  • Advanced Flower Capital has a portfolio concentrated in the cannabis sector, which remains subject to continued industry volatility, limited capital inflows, and ongoing legal and regulatory risks due to federal prohibition, increasing potential for asset impairments and write-downs that could reduce revenue and earnings stability.
  • The announced conversion from a REIT to a BDC broadens the investment universe but introduces new risks, as lending to operators without real estate collateral may elevate credit risk and reduce recovery rates in defaults, which may negatively affect future net interest margins, loan quality, and earnings.
  • Heavy reliance on external financing and a limited willingness to issue equity given discounted stock price constrains AFC's ability to fund new growth, leaving the company exposed to capital market volatility and potentially limiting expansion of revenue and earnings if credit conditions tighten.
  • Uncertainty around federal rescheduling and potential regulatory change creates execution risk; while more capital could flow into the industry and improve existing loan recoveries, greater banking acceptance and increased competition could erode AFC's market share, compress lending spreads, and negatively impact future revenue growth and long-term profitability.

Valuation

How have all the factors above been brought together to estimate a fair value?

  • The analysts have a consensus price target of $8.0 for Advanced Flower Capital based on their expectations of its future earnings growth, profit margins and other risk factors.
  • In order for you to agree with the analysts, you'd need to believe that by 2029, revenues will be $54.5 million, earnings will come to $39.1 million, and it would be trading on a PE ratio of 7.1x, assuming you use a discount rate of 9.2%.
  • Given the current share price of $3.17, the analyst price target of $8.0 is 60.4% higher.
  • We always encourage you to reach your own conclusions though. So sense check these analyst numbers against your own assumptions and expectations based on your understanding of the business and what you believe is probable.

Have other thoughts on Advanced Flower Capital?

Create your own narrative on this stock, and estimate its Fair Value using our Valuator tool.

Create Narrative

How well do narratives help inform your perspective?

Disclaimer

AnalystConsensusTarget is a tool utilizing a Large Language Model (LLM) that ingests data on consensus price targets, forecasted revenue and earnings figures, as well as the transcripts of earnings calls to produce qualitative analysis. The narratives produced by AnalystConsensusTarget are general in nature and are based solely on analyst data and publicly-available material published by the respective companies. These scenarios are not indicative of the company's future performance and are exploratory in nature. Simply Wall St has no position in the company(s) mentioned. Simply Wall St may provide the securities issuer or related entities with website advertising services for a fee, on an arm's length basis. These relationships have no impact on the way we conduct our business, the content we host, or how our content is served to users. The price targets and estimates used are consensus data, and do not constitute a recommendation to buy or sell any stock, and they do not take account of your objectives, or your financial situation. Note that AnalystConsensusTarget's analysis may not factor in the latest price-sensitive company announcements or qualitative material.

Read more narratives

Fair Value vs Share Price

US$8
vs US$3.1360.9% undervalued intrinsic discount
PastFuture-9m63m202020222024202620282029Revenue US$54.5mEarnings US$39.1m
171.7%
Revenue growth
71.7%
Profit margin

Recent News & Updates

No updates

Recent updates

No updates

Stay ahead on Advanced Flower Capital

  • Fair value estimate changes
  • Narrative and analyst updates
  • Key company announcements

Company analysis

High growth potential with slight risk.

Market capUS$73.6m
PB0.4x
Estimated Growth50.9%
Dividend Yield6.4%
Full analysis

CEO & management

Daniel Neville
CEO
2.5yrs
CEO Tenure

Advanced Flower Capital Inc. originates, structures, underwrites, invests in, and manages senior secured loans and other types of mortgage loans and debt securities for established companies operating in the cannabis industry.